カテゴリ： Grand View Research, 世界, 医療/バイオ

止血剤・組織密閉剤の世界市場：製品別（局所止血剤、接着剤・組織シーラント）、地域別、セグメント予測

◆英語タイトル：Hemostasis And Tissue Sealing Agents Market Size, Share & Trends Analysis Report By Product (Topical Hemostat, Adhesives & Tissue Sealant), By Region, And Segment Forecasts, 2019 - 2026
◆商品コード：GVW903091
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2019年2月28日
◆ページ数：15
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single UserUSD4,950 ⇒換算￥514,800見積依頼/購入/質問フォーム
Multi UserUSD5,950 ⇒換算￥618,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD7,950 ⇒換算￥826,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートでは、止血剤・組織密閉剤の世界市場について調査・分析し、止血剤・組織密閉剤の世界市場動向、止血剤・組織密閉剤の世界市場規模、市場予測、セグメント別止血剤・組織密閉剤市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global hemostasis and tissue sealing agents market size is expected to reach USD 10.34 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 8.7% during the forecast period. The agents have gained popularity over time due to their ability to prevent blood loss. Rapid growth of minimal invasive technology and demand for faster recovery by patients is expected to promote market growth over the forecast period.
According to the Centers for Disease Control and Prevention (CDC), approximately 150 million of American population is currently suffering from at least one chronic condition, which leads to surgeries and even mortality at times. An estimate over the rising incidence was made by the CDC, which concluded that over 48% of the entire American population is expected to suffer by chronic condition.

The hemostasis and tissue sealing agents market is expected to witness lucrative growth over the next seven years owing to, an increase in demand supported by rising surgery volumes. Growth in geriatric population and prevalence of chronic conditions are the impact rendering drivers for this industry.

Further key findings from the report suggest:

• The hemostats market is expected to expand at a CAGR of over 8.7% over the forecast period owing to the rise in global volume of surgeries and applicability of the product across a variety of surgeries to avoid occurrence of hypovolemic shock, thrombocytopenia, blood transfusions, and post-operative complications

• Flowable hemostats are a combination of active and mechanical agents. They function by blocking blood flow and also converting fibrinogen into fibrin for coagulation. This segment is expected to witness a lucrative CAGR of over 10.0% from 2018 to 2026

• Some key players operating in the hemostasis and tissue sealing agents market include Johnson & Johnson; CryoLife Inc.; Pfizer; C R Bard; B Braun; Covidien; and Smith & Nephew. Market participants are involved in technological advancements to ensure sustainability and regional presence

• For instance, in March 2015, Ethicon announced higher efficiency of EVARREST fibrin sealant patch as compared to its substitute, TachoSil patch (Baxter). Further study would be conducted at the St. Vincent Heart Centre of Indiana to understand added advantages that the product can offer.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hemostasis and Tissue Sealing Agents Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.1.1. Increasing incidence rate of chronic conditions
3.7.1.2. Applicability of products across multiple conditions
3.7.1.3. Growing geriatric population
3.7.2. Market Restraint Analysis
3.7.2.1. Stringent regulations and approvals
3.7.3. Industry Challenges
3.7.3.1. Associated complications
3.8. Hemostasis and Tissue Sealing Agents: Market Analysis Tools
3.8.1. Industry Analysis – Porter’s
3.8.1.1. Supplier Power: (High)
3.8.1.2. Buyer Power: (Moderate)
3.8.1.3. Substitution Threat: (Moderate)
3.8.1.4. Threat from new entrant: (High)
3.8.1.5. Competitive rivalry: (High)
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
3.8.5. Case Studies
Chapter 4. Hemostasis and Tissue Sealing Agents Market: Segment Analysis, By Product, 2015 – 2026 (USD Million)
4.1. Definitions & Scope
4.2. Component market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Hemostasis and Tissue Sealing Agents Market, By Product, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Topical hemostats
4.5.1.1. Active
4.5.1.2. Mechanical
4.5.1.3. Flowable
4.5.2. Adhesive & tissue sealant
4.5.2.1. Synthetic
4.5.2.2. Natural
4.5.2.3. Adhesion barrier
Chapter 5. Hemostasis and Tissue Sealing Agents Market: Regional Market Analysis, By Region, 2015 – 2026 (USD Million)
5.1. Definitions & Scope
5.2. Regional market share analysis, 2018 & 2026
5.3. Regional Market Dashboard
5.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
5.5. Regional Market Share and Leading Players, 2018
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
5.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
5.7. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2026:
5.8. North America
5.8.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.8.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.8.3. U.S.
5.8.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.8.4. Canada
5.8.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9. Europe
5.9.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.9.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.3. Germany
5.9.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.4. U.K.
5.9.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.5. France
5.9.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.6. Italy
5.9.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.7. Spain
5.9.7.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10. Asia Pacific
5.10.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.10.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.3. China
5.10.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.4. Japan
5.10.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.5. India
5.10.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.6. Thailand
5.10.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.7. South Korea
5.10.7.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11. Latin America
5.11.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.11.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.3. Brazil
5.11.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.4. Mexico
5.11.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.5. Argentina
5.11.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.6. Colombia
5.11.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12. Middle East and Africa
5.12.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.12.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12.3. South Africa
5.12.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12.4. Saudi Arabia
5.12.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12.5. UAE
5.12.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
Chapter 6. Hemostasis and Tissue Sealing Agents Market – Competitive Analysis
6.1. Recent developments & impact analysis, by key market participants
6.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2018
6.4. Public Companies
6.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
6.4.2. Company Market Share/Ranking, by region
6.4.3. Competitive Dashboard Analysis
6.4.3.1. Market Differentiators
6.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
6.5. Private Companies
6.5.1. List of key emerging companies’ /technology disruptors/innovators
6.5.2. Funding Outlook (Optional)
6.5.3. Regional network map
6.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
6.6. Supplier Ranking
6.7. Key companies profiled
6.7.1. Johnson & Johnson
6.7.1.1. Company Overview
6.7.1.2. Financial Performance
6.7.1.3. Product Benchmarking
6.7.1.4. Strategic Initiatives
6.7.2. CryoLife Inc.
6.7.2.1. Company Overview
6.7.2.2. Financial Performance
6.7.2.3. Product Benchmarking
6.7.2.4. Strategic Initiatives
6.7.3. Advance Medical Solution (AMS) Group Plc.
6.7.3.1. Company Overview
6.7.3.2. Financial Performance
6.7.3.3. Product Benchmarking
6.7.3.4. Strategic Initiatives
6.7.4. Cohera Medical Inc.
6.7.4.1. Company Overview
6.7.4.2. Financial Performance
6.7.4.3. Product Benchmarking
6.7.4.4. Strategic Initiatives
6.7.5. Integra Life Sciences Corporation
6.7.5.1. Company Overview
6.7.5.2. Financial Performance
6.7.5.3. Product Benchmarking
6.7.5.4. Strategic Initiatives
6.7.6. Pfizer Inc.
6.7.6.1. Company Overview
6.7.6.2. Financial Performance
6.7.6.3. Product Benchmarking
6.7.6.4. Strategic Initiatives
6.7.7. C R Bard Inc.
6.7.7.1. Company Overview
6.7.7.2. Financial Performance
6.7.7.3. Product Benchmarking
6.7.7.4. Strategic Initiatives
6.7.8. Cohesion Technologies Inc.
6.7.8.1. Company Overview
6.7.8.2. Financial Performance
6.7.8.3. Product Benchmarking
6.7.8.4. Strategic Initiatives
6.7.9. HyperBranch Medical Technology.
6.7.9.1. Company Overview
6.7.9.2. Financial Performance
6.7.9.3. Product Benchmarking
6.7.9.4. Strategic Initiatives
6.7.10. Biomet Inc.
6.7.10.1. Company Overview
6.7.10.2. Financial Performance
6.7.10.3. Product Benchmarking
6.7.10.4. Strategic Initiatives
6.7.11. Covidien Plc.
6.7.11.1. Company Overview
6.7.11.2. Financial Performance
6.7.11.3. Product Benchmarking
6.7.11.4. Strategic Initiatives
6.7.12. B Braun Medical Inc.
6.7.12.1. Company Overview
6.7.12.2. Financial Performance
6.7.12.3. Product Benchmarking
6.7.12.4. Strategic Initiatives
6.7.13. Smith & Nephew.
6.7.13.1. Company Overview
6.7.13.2. Financial Performance
6.7.13.3. Product Benchmarking
6.7.13.4. Strategic Initiatives
Chapter 7. KOL Commentary
Chapter 8. Recommendation

List of Tables

Table 1 North America Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 2 U.S. Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 3 Canada Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 4 Europe Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 5 U.K. Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 6 Germany Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 7 France Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 8 Italy Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 9 Spain Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 10 Asia Pacific Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 11 Japan Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 12 China Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 13 India Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 14 Thailand Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 15 South Korea Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 16 Latin America Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 17 Brazil Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 18 Mexico Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 19 Argentina Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 20 Colombia Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 21 MEA Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 22 South Africa Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 23 Saudi Arabia Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 24 UAE Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Global hemostasis and tissue sealing agents market segmentation
Figure 9 Global hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 10 Hemostasis and tissue sealing agents market dynamics
Figure 11 Number of individual in the U.S. with chronic condition (Estimates in Millions)
Figure 12 Rising geriatric population, by geography, (% increase)
Figure 13 Key opportunities prioritized
Figure 14 Hemostasis and tissue sealing agents market Porter’s analysis
Figure 15 Hemostasis and tissue sealing agents company market share, 201
Figure 16 Hemostasis and tissue sealing agents market PESTEL analysis
Figure 17 Hemostasis and tissue sealing agents market share, by product, 2018 & 2026
Figure 18 Topical hemostats market, 2015 - 2026 (USD Million)
Figure 19 Active hemostats market, 2015 - 2026 (USD Million)
Figure 20 Mechanical hemostats market, 2015 - 2026 (USD Million)
Figure 21 Flowable hemostats market, 2015 - 2026 (USD Million)
Figure 22 Adhesives and tissue sealants market, 2015 - 2026 (USD Million)
Figure 23 Synthetic tissue sealants market, 2015 - 2026 (USD Million)
Figure 24 Natural tissue sealants market, 2015 - 2026 (USD Million)
Figure 25 Adhesion barrier products market, 2015 - 2026 (USD Million)
Figure 26 Hemostasis and tissue sealing agents market share, by region, 2018 & 2026
Figure 27 North America hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 28 U.S. hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 29 Canada hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 30 Europe hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 31 U.K. hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 32 Germany hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 33 France hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 34 Italy hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 35 Spain hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 36 Asia Pacific hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 37 Japan hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 38 China hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 39 Thailand hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 40 South korea hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 41 India hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 42 Latin America hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 43 Brazil hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 44 Mexico hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 45 Argentina hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 46 Colombia hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 47 MEA hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 48 South Africa hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 49 Saudi arabia hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 50 UAE hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)

【掲載企業】

Johnson & Johnson、CryoLife Inc.、Advance Medical Solution (AMS) Group Plc.、Cohera Medical Inc.、Integra Life Sciences Corporation、Pfizer Inc.、C R Bard Inc.、Cohesion Technologies Inc.、HyperBranch Medical Technology.、Biomet Inc.、Covidien Plc.、B Braun Medical Inc.、Smith & Nephew.

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[止血剤・組織密閉剤の世界市場：製品別（局所止血剤、接着剤・組織シーラント）、地域別、セグメント予測]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 歯科診療管理ソフトウェアの世界市場：導入形態別（オンプレミス、Webベース、クラウドベース）、地域別、セグメント予測
    GVW903063 / Grand View Research / 2019年2月27日 / 本調査レポートでは、歯科診療管理ソフトウェアの世界市場について調査・分析し、歯科診療管理ソフトウェアの世界市場動向、歯科診療管理ソフトウェアの世界市場規模、市場予測、セグメント別歯科診療管理ソフトウェア市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global dental practice management software market size is expected to reach USD 3.4 billion by 2026, based on a new report by Grand View Research, Inc., registering a 10.0% CAGR during the forecast period. Market growth can be attributed to increasing geriatric population and increase in oral healthcare expenditure. According to the U.S. Census Bureau’s International Data Base, the population of individuals 45 years and older is expected to grow by about 12.0% between 2015 and 2025, while the total U.S. population will increase by about 8.0% during the same period. Furthermore, the expected increase in oral health insurance...
  2. ビタミンD試験の世界市場分析：試験タイプ別（25-ヒドロキシビタミンD試験; 1,25-ジヒドロキシビタミンD試験）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、中南米、MEA）、セグメント予測、2014-2025
    GVIEW707880 / Grand View Research / 2017年5月31日 / 本調査レポートでは、ビタミンD試験の世界市場について調査・分析し、ビタミンD試験の世界市場動向、ビタミンD試験の世界市場規模、市場予測、セグメント別ビタミンD試験市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global vitamin D testing market is expected to reach USD 1.1 billion by 2025, according to a new report by Grand View Research, Inc. Global increase in geriatric population as well as cases of chronic illnesses is likely to drive the market during the forecast period. Furthermore, increase in investment for development and commercialization of various accurate, innovative, and easy-to-use tests by various market players and governments is likely to drive the market growth. For instance, in January 2017, Future Diagnostics and DIA source received a grant of EUR 1.4 million from the European Commission to develop a unique...
  3. 在宅医療の世界市場：コンポーネント別（サービス、機器）、地域別、セグメント予測
    GVW903093 / Grand View Research / 2019年2月27日 / 本調査レポートでは、在宅医療の世界市場について調査・分析し、在宅医療の世界市場動向、在宅医療の世界市場規模、市場予測、セグメント別在宅医療市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global home healthcare market size is anticipated to reach USD 557.57 billion by 2026 registering a CAGR of 7.8%, according to a new report by Grand View Research, Inc. This growth can be attributed to improved patient outcome, cost-efficiency, and patient convenience provided by home healthcare. In addition, rising cases of diseases, such as dementia, Alzheimer’s, and orthopedic conditions, are expected to fuel market growth. For instance, according to the WHO, nearly 50 million individuals worldwide were suffering from dementia in 2017 and the number is anticipated to reach nearly 82 million by 2030. According to an article by...
  4. 腫瘍学に基づくインビボCROの世界市場分析：指示別（血液がん、固形腫瘍）、モデル別（同系モデル、患者由来異種移植片（PDX）、異種移植片）、地域別、セグメント予測、2014-2025
    GVIEW707611 / Grand View Research / 2017年5月26日 / 本調査レポートでは、腫瘍学に基づくインビボCROの世界市場について調査・分析し、腫瘍学に基づくインビボCROの世界市場動向、腫瘍学に基づくインビボCROの世界市場規模、市場予測、セグメント別腫瘍学に基づくインビボCRO市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global oncology based in-vivo CRO market is expected to reach USD 1.5 billion by 2025, according to a new report by Grand View Research, Inc. The use of Contract Research Organization (CRO) oncology services helps the manufacturers/sponsors to provide complete attention on the production capacity and at enhancing their in-house processes.Furthermore, the pressure from the increasing competition due to patent expirations, rapid growth of generics, and introduction of biosimilar equivalents are propelling the pharmaceutical companies to take the aid of such organizations. Hence, it can be predicted that the oncology based in-vivo CRO market may witness lucrative growth over...
  5. 患者エンゲージメントソリューションの世界市場：配信タイプ別（Web、クラウド、オンプレミス）、コンポーネント別、最終用途別、アプリケーション別、セグメント予測
    GVW903133 / Grand View Research / 2019年2月28日 / 本調査レポートでは、患者エンゲージメントソリューションの世界市場について調査・分析し、患者エンゲージメントソリューションの世界市場動向、患者エンゲージメントソリューションの世界市場規模、市場予測、セグメント別患者エンゲージメントソリューション市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global patient engagement solutions market size is expected to reach USD 56.92 billion by 2026, according to a new report by Grand View Research Inc. It is anticipated to expand at a CAGR of 20.43% during the forecast period. The supportive government initiatives and rising usage and awareness regarding mobile healthcare services are expected to impel the growth. Rising prevalence of chronic conditions is the preliminary factor expected to boost the growth of the patient engagement solutions management market. The mortality rate of diabetic patients was over 1.0 million in 2012, as stated by the World Health Organization (WHO)....
  6. MRI（磁気共鳴画像法）の世界市場：アーキテクチャ別（オープンシステム、クローズドシステム）、磁場強度別（低磁場、中磁場、高磁場）、アプリケーション別、最終用途別、セグメント予測
    GVW903109 / Grand View Research / 2019年2月27日 / 本調査レポートでは、MRI（磁気共鳴画像法）の世界市場について調査・分析し、MRI（磁気共鳴画像法）の世界市場動向、MRI（磁気共鳴画像法）の世界市場規模、市場予測、セグメント別MRI（磁気共鳴画像法）市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global MRI market size is expected to reach an approximate value of USD 5.8 billion by 2026, according to a report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.3% during the forecast period. Constant introduction of advanced disease diagnostic technologies is primarily boosting the growth. Rapid growth of MRI sector is attributed to the rising prevalence of chronic diseases which require early diagnosis and timely treatment to prevent late stage complications. Also, rising number of road accidents leading to injuries and complications are augmenting the demand for this modality. The musculoskeletal and...
  7. 手術用トレイの世界市場：製品別（手術室用、血管造影用、眼科）、最終用途別（病院、診療所）、地域別、セグメント予測
    GVIEW805111 / Grand View Research / 2018年4月23日 / 本調査レポートでは、手術用トレイの世界市場について調査・分析し、手術用トレイの世界市場動向、手術用トレイの世界市場規模、市場予測、セグメント別手術用トレイ市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global procedure trays market size is expected to reach USD 18.9 billion by 2025, according to a new study by Grand View Research Inc., progressing at a CAGR of 10.5% during the forecast period. Increasing number of surgeries across the world is providing a significant boost to the market. Moreover, governments worldwide are encouraging usage of single-use sterile instruments to avoid infections. This, in turn, is acting as one of the key trends stoking market growth. Along with the increasing number of surgical procedures, the demand for advanced logistics and inventory management is also growing. Patients are increasingly preferring...
  8. 神経血管装置の世界市場：治療用途別（脳卒中、脳動脈狭窄、脳動脈瘤）装置種類別、地域別、セグメント予測
    GVW903122 / Grand View Research / 2019年2月28日 / 本調査レポートでは、神経血管装置の世界市場について調査・分析し、神経血管装置の世界市場動向、神経血管装置の世界市場規模、市場予測、セグメント別神経血管装置市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global neurovascular devices market size is estimated to reach USD 3.1 billion by 2026, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 5.3% over the forecast years. Preference for minimally invasive surgeries in the treatments of brain aneurysm and stroke is expected to be the key factor augmenting the market growth. Technological advancements have increased life expectancy, leading to a consequent increase in geriatric population. According to a report published by United Nations, geriatric population (aged 60 years and above) is projected to increase by 56% from...
  9. 静脈瘤治療装置の世界市場：種類別（静脈内切除、硬化療法、外科的結紮・剥離）、地域別、セグメント予測
    GVW903175 / Grand View Research / 2019年2月28日 / 本調査レポートでは、静脈瘤治療装置の世界市場について調査・分析し、静脈瘤治療装置の世界市場動向、静脈瘤治療装置の世界市場規模、市場予測、セグメント別静脈瘤治療装置市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global varicose veins treatment devices market is expected to reach USD 1.7 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 6.3% during the forecast period. Rising investments by the key healthcare companies to develop innovative and effective products is likely to drive the growth. Varicose veins can be unsightly and can lead to considerable discomfort in some cases. Available treatments for varicose veins have improved since the last few years. Various healthcare providers are offering minimally invasive techniques such as radiofrequency ablation and laser therapies. Due...
  10. 血流予備比の世界市場：用途別（多血管性、単血管性）、製品別（モニタリングシステム、ガイドワイヤー）、地域別、セグメント予測
    GVW903077 / Grand View Research / 2019年2月28日 / 本調査レポートでは、血流予備比の世界市場について調査・分析し、血流予備比の世界市場動向、血流予備比の世界市場規模、市場予測、セグメント別血流予備比市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global fractional flow reserve market size is expected to reach USD 1,080.3 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 10.5% during the forecast period. Widening base of cardiovascular diseases coupled with mounting cases of diabetes in developed as well as developing economies is escalating the growth of the market. Additionally, launch of novel devices in fractional flow reserve (FFR) market such as guidewires and monitoring systems are also anticipated to aid market growth. For instance, in October 2017, GE Healthcare and Medis, a Dutch based imaging software provider...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆